Menstrual Blood‑Derived Endometrial Stem Cells Protect the Integrity of the Intestinal Barrier by Inhibiting the NF‐κB/Snail Signaling Pathway
Cell Biology International · 2025
DOI: 10.1002/cbin.70040 ↗At a glance
Journal article in Cell Biology International, 2025. Written by Tao Ruan and 4 co-authors. Institution: Stem Cell and Biotherapy Engineering Research Center of Henan, College of Life Science and Technology, Xinxiang Medical University, Xinxiang, China. Major MEDLINE topics: Snail Family Transcription Factors, NF-kappa B, Intestinal Mucosa, Endometrium. Cited 1 times so far (Crossref); 45 references. Funded by: This study was supported by the Scientific and Technological Foundation of Henan Province in China (222102310382), Key Research Projects in the Colleges of Hen….
Abstract (original language)
Inflammatory bowel diseases (IBDs), including Crohn's disease (CD) and ulcerative colitis (UC) are chronic recurrent nonspecific intestinal disease. Current IBD therapeutics cannot fundamentally change the natural course of IBD. Therefore, it is of great significance to find new treatment strategies for IBD. Preclinical and clinical studies have shown that mesenchymal stem cells (MSCs) are a promising therapeutic approach. However, the mechanism by which MSCs alleviate colitis and how MSCs affect intestinal mucosal barrier is still unclear. LPS‐exposed human colonic epithelial cancer cell lines Caco2 and HT29. Dextran sulfate sodium (DSS)‐induced IBD mouse were treated with MenSCs. We found that LPS downregulates intercellular junction proteins and induces the production of inflammatory cytokines in intestinal epithelial cells. MenSCs reduced paracellular permeability and restored barrier integrity in Caco2 cells. In Vivo, MenSCs mitigated DSS‐induced colitis in mice by reducing body weight loss, colonic shortening, and disease activity index scores and by inhibiting the expressions of the pro‐inflammatory cytokines IL‐1β, IL‐6, and TNF‐α. MenSCs increased the expression of TJ proteins, improved the destruction of tight junction (TJ) structures, and reduced intestinal epithelial permeability. Furthermore, MenSCs could inhibit NF‐κB p65 phosphorylation and the expression of Snail and prevent Snail nuclear localization, thereby maintaining tight and adherens junctions. Our findings demonstrate that MenSCs alleviate intestinal inflammation and enhance barrier function by suppressing the NF‐κB/Snail signaling axis, offering a promising therapeutic strategy for inflammatory bowel diseases.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Stem Cell and Biotherapy Engineering Research Center of Henan, College of Life Science and Technology, Xinxiang Medical University, Xinxiang, China.
- Henan Joint International Research Laboratory of Stem Cell Medicine, School of Medical Engineering, Xinxiang Medical University, Xinxiang, China.
- School of Public Health, Xinxiang Medical University, Xinxiang, China.
ORCID profiles: Juntang Lin
Funding
- This study was supported by the Scientific and Technological Foundation of Henan Province in China (222102310382), Key Research Projects in the Colleges of Hen…
Cite
APA
Ruan, T., Han, J., Xue, C., Liang, H., & Lin, J. (2025). Menstrual Blood‑Derived Endometrial Stem Cells Protect the Integrity of the Intestinal Barrier by Inhibiting the NF‐κB/Snail Signaling Pathway. Cell Biology International. https://doi.org/10.1002/cbin.70040
Vancouver
Ruan T, Han J, Xue C, Liang H, Lin J. Menstrual Blood‑Derived Endometrial Stem Cells Protect the Integrity of the Intestinal Barrier by Inhibiting the NF‐κB/Snail Signaling Pathway. Cell Biology International. 2025. doi:10.1002/cbin.70040
BibTeX
@article{Ruan2025,
author = {Ruan, Tao and Han, Jiaming and Xue, Chengxu and Liang, Haiyan and Lin, Juntang},
title = {Menstrual Blood‑Derived Endometrial Stem Cells Protect the Integrity of the Intestinal Barrier by Inhibiting the NF‐κB/Snail Signaling Pathway},
journal = {Cell Biology International},
year = {2025},
doi = {10.1002/cbin.70040}
}
EUVIMED